These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 954813)

  • 21. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.
    Resul B; Lewander T; Ringdahl B; Zetterström T; Dahlbom R
    Eur J Pharmacol; 1982 May; 80(2-3):209-15. PubMed ID: 7106176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activity.
    Shannon HE; Sheardown MJ; Bymaster FP; Calligaro DO; Delapp NW; Gidda J; Mitch CH; Sawyer BD; Stengel PW; Ward JS; Wong DT; Olesen PH; Suzdak PD; Sauerberg P; Swedberg MD
    J Pharmacol Exp Ther; 1997 May; 281(2):884-94. PubMed ID: 9152398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The central and peripheral effectiveness of two oxotremorine-antagonists determined using oxotremorine-induced tremor and salivation.
    Eicholzer A; Ogren SO
    J Pharm Pharmacol; 1977 Oct; 29(10):609-11. PubMed ID: 21240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
    Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(3):209-14. PubMed ID: 1163240
    [No Abstract]   [Full Text] [Related]  

  • 26. Antioxotremorine action of propranolol.
    Ganguly DK
    Br J Pharmacol; 1976 Jan; 56(1):21-4. PubMed ID: 1252661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.
    Freedman SB; Harley EA; Patel S; Newberry NR; Gilbert MJ; McKnight AT; Tang JK; Maguire JJ; Mudunkotuwa NT; Baker R
    Br J Pharmacol; 1990 Nov; 101(3):575-80. PubMed ID: 2076477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
    Ringdahl B; Katz ED; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the muscarinic receptor: pH dependence of the action of some cholinergic drugs on the guinea-pig ileum.
    Jacob LS; Gero A
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):306-15. PubMed ID: 4748784
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro.
    Eglen RM; Harris GC
    Br J Pharmacol; 1993 Aug; 109(4):946-52. PubMed ID: 8401947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Structure- and conformation-activity relationship of heterocyclic acetylcholine analogs. 13. Cholinergic properties of tertiary and quaternary 4-acetoxyquinuclidines].
    Lambrecht G
    Arzneimittelforschung; 1982; 32(2):130-4. PubMed ID: 7199915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
    Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the interaction between muscarinic M2 receptors and beta-adrenoceptor subtypes in guinea-pig isolated ileum.
    Reddy H; Watson N; Ford AP; Eglen RM
    Br J Pharmacol; 1995 Jan; 114(1):49-56. PubMed ID: 7712028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of facilitation and muscarinic or alpha-adrenergic inhibition of acetylcholine and noradrenaline secretion from peripheral nerves.
    Alberts P
    Acta Physiol Scand Suppl; 1982; 506():1-39. PubMed ID: 6293252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitation, and muscarinic and alpha-adrenergic inhibition of the secretion of 3H-acetylcholine and 3H-noradrenaline from guinea-pig ileum myenteric nerve terminals.
    Alberts P; Stjärne L
    Acta Physiol Scand; 1982 Sep; 116(1):83-92. PubMed ID: 6130670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic receptors in rat sympathetic ganglia.
    Brown DA; Fatherazi S; Garthwaite J; White RD
    Br J Pharmacol; 1980 Dec; 70(4):577-92. PubMed ID: 6258681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic receptors in the mammalian central nervous system.
    Yamamura HI; Wastek G; Chang KJ; Snyder SH
    Proc West Pharmacol Soc; 1976; 19():13-8. PubMed ID: 995977
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationships between chemical structure and affinity for postganglionic acetylcholine receptors of the guinea-pig ileum.
    Abramson FB; Barlow RB; Franks FM; Pearson JD
    Br J Pharmacol; 1974 May; 51(1):81-93. PubMed ID: 4441797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contraction and [3H]QNB binding in collagenase isolated fundic smooth muscle cells.
    Seidel ER; Johnson LR
    Am J Physiol; 1983 Aug; 245(2):G270-6. PubMed ID: 6881350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the antimuscarinic action of p-fluorohexahydrosiladifenidol in ileal and tracheal smooth muscle.
    Ehlert FJ; Hsu JC; Leung K; Lee AG; Shehnaz D; Griffin MT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):592-600. PubMed ID: 15456838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.